Dopamine agonists and pituitary tumor shrinkage.

Bevan, J S; Webster, J; Burke, C W; Scanlon, M F

Bevan, J S; Webster, J; Burke, C W; Scanlon, M F.

Affiliation

Bevan JS; Division of Endocrinology, Diabetes and Metabolism, University of Wales College of Medicine, Heath Park, Cardiff, UK.

Endocr Rev ; 13(2): 220-40, 1992 May.

Article in En | MEDLINE | ID: mdl-1352243

Subject(s)

Adenoma/drug therapy; Dopamine Agents/therapeutic use; Pituitary Neoplasms/drug therapy; Pregnancy Complications, Neoplastic/drug therapy; Prolactinoma/drug therapy; Adenoma/metabolism; Adenoma/pathology; Bromocriptine/therapeutic use; Cell Division; Female; Humans; Male; Meta-Analysis as Topic; Pituitary Neoplasms/metabolism; Pregnancy; Pregnancy Complications, Neoplastic/metabolism; Pregnancy Complications, Neoplastic/pathology; Prolactin/blood; Prolactinoma/metabolism; Prolactinoma/pathology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pituitary Neoplasms / Pregnancy Complications, Neoplastic / Dopamine Agents / Prolactinoma / Adenoma Type of study: Systematic_reviews Limits: Female / Humans / Male / Pregnancy Language: En Journal: Endocr Rev Year: 1992 Type: Article Affiliation country: United kingdom

Search on Google

XML

PubMed Links